ImmunityBio, Inc. Quarterly Interest Expense in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
ImmunityBio, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2015 to Q3 2024.
  • ImmunityBio, Inc. Interest Expense for the quarter ending September 30, 2024 was $29.3M, a 16.3% decline year-over-year.
  • ImmunityBio, Inc. Interest Expense for the twelve months ending September 30, 2024 was $121M, a 3.91% decline year-over-year.
  • ImmunityBio, Inc. annual Interest Expense for 2023 was $129M, a 103% increase from 2022.
  • ImmunityBio, Inc. annual Interest Expense for 2022 was $63.5M, a 328% increase from 2021.
  • ImmunityBio, Inc. annual Interest Expense for 2021 was $14.8M, a 63.6% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $121M $29.3M -$5.7M -16.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $126M $29.8M -$2.44M -7.57% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $129M $29.5M -$333K -1.12% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $129M $32.1M +$3.56M +12.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $126M $35M +$18.3M +109% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $107M $32.2M +$22.5M +232% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $84.8M $29.8M +$21.3M +251% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $63.5M $28.6M +$24.1M +536% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $39.4M $16.8M +$13.2M +364% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $26.3M $9.7M +$6.12M +171% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $20.2M $8.49M +$5.32M +168% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $14.8M $4.49M +$1.65M +58.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 $13.2M $3.61M +$1.39M +62.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $11.8M $3.58M +$1.45M +68.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $10.4M $3.17M +$1.28M +67.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $9.07M $2.84M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $2.23M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.12M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.89M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2018 $614K $33K -$4K -10.8% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-07
Q4 2017 $618K $34K -$3K -8.11% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-12
Q3 2017 $621K $393K +$364K +1255% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $257K $154K +$154K Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $103K $37K +$37K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $66K $37K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 $29K +$29K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.